This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Celator Pharmaceuticals, Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Innovations in Cancer Treatment by John Redman
Introduction
John Redman is a notable inventor based in Mullica Hills, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. His work primarily focuses on developing effective drug combinations for solid tumors.
Latest Patents
John Redman holds a patent for "Fixed ratio drug combination treatments for solid tumors." This patent describes methods for treating cancer by administering a pharmaceutical composition that comprises a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. Such methods are particularly useful in treating cancer patients with advanced solid tumors. He has 1 patent to his name.
Career Highlights
John Redman is associated with Celator Pharmaceuticals, Inc., where he has been instrumental in advancing cancer treatment methodologies. His work has garnered attention for its potential to improve patient outcomes in oncology.
Collaborations
He has collaborated with notable colleagues, including Andrew S. Janoff and Lawrence D. Mayer, to further enhance the research and development of cancer therapies.
Conclusion
John Redman's innovative contributions to cancer treatment exemplify the impact of dedicated inventors in the medical field. His work continues to inspire advancements in oncology and improve the lives of patients facing challenging diagnoses.